Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants

Biomaterials

Volumn 32, Issue 28, 2011, Pages 6815-6822

  Petersen, Latrisha K ^a   Ramer Tait, Amanda E ^b   Broderick, Scott R ^a,b   Kong, Chang Sun ^a,b   Ulery, Bret D ^a   Rajan, Krishna ^a,b   Wannemuehler, Michael J ^b   Narasimhan, Balaji ^a  

^a Iowa State University of Science and Technology   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Combinatorial; High throughput; Nanoparticles; Polyanhydrides; Vaccine adjuvants

Indexed keywords

ALKYL ETHERS; AMPHIPHILICS; ANTIGEN PRESENTING CELLS; BIODEGRADABLE POLYANHYDRIDES; CELLULAR ACTIVATION; COMBINATORIAL; DENDRITIC CELLS; HIGH THROUGHPUT; HYDROXYL END GROUP; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INFORMATICS; INNATE IMMUNE RESPONSE; MATERIALS DESIGN; MOLECULAR CHARACTERISTICS; MOLECULAR DESCRIPTORS; MOLECULAR DESIGN; MOLECULAR PATTERNS; NATURAL INFECTION; POLYANHYDRIDES; PROTEIN RELEASE; PROTEIN STRUCTURES; TOXIC SIDE EFFECTS; VACCINE DELIVERY;

DESIGN; ETHERS; HYDROPHOBICITY; IMMUNOLOGY; INFORMATION SCIENCE; MOLECULAR OXYGEN; NANOPARTICLES; TOXIC MATERIALS; VACCINES;

PATHOGENS;

ADJUVANT; ALKYL ETHER; HYDROXYL GROUP; NANOPARTICLE; OXYGEN; POLYANHYDRIDE;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BIODEGRADABILITY; CELL ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; HIGH THROUGHPUT SCREENING; HYDROPHOBICITY; IMMUNOPHENOTYPING; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN STRUCTURE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; IMMUNITY, INNATE; MATERIALS TESTING; MICE; NANOPARTICLES; POLYANHYDRIDES;

EID: 79960558240     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.063     Document Type: Article

References (46)

1. Zepp F. Principles of vaccine design-lessons from nature. Vaccine 2010, 28:C14-C24.
2. Foster N., Hirst B.H. Exploiting receptor biology for oral vaccination with biodegradable particulates. Adv Drug Deliv Rev 2005, 57:431-450.
3. Janeway C.A., Travers P., Shlomichik M.J., Walport M. Immunobiology: the immune system in health and disease 2005, Garland Science, New York. 6th ed.
4. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999, 5:1249-1255.
5. Nau G.J., Schlesinger A., Richmond J.F.L., Young R.A. Cumulative Toll-like receptor activation in human macrophages treated with whole bacteria. J Immunol 2003, 170:5203-5209.
6. Carrillo-Conde B., Schiltz E., Yu J., Chris Minion F., Phillips G.J., Wannemuehler M.J., et al. Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens. Acta Biomater 2010, 6:3110-3119.
7. Lopac S.K., Torres M.P., Wilson-Welder J.H., Wannemuehler M.J., Narasimhan B. Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres. J Biomed Mater Res B 2009, 91:938-947.
8. Petersen L.K., Determan A.S., Westgate C., Bendickson L., Nilsen-Hamilton M., Narasimhan B. Lipocalin-2-loaded amphiphilic polyanhydride microparticles accelerate cell migration. J Biomater Sci Polym Ed 2010, 22:1237-1252.
9. Petersen L.K., Sackett C.K., Narasimhan B. A novel, high throughput method to study in vitro protein release from polymer nanospheres. J Comb Chem 2010, 12:51-56.
10. Petersen L.K., Sackett C.K., Narasimhan B. High-throughput analysis of protein stability in polyanhydride nanoparticles. Acta Biomater 2010, 6:3873-3881.
11. Torres M.P., Determan A.S., Anderson G.L., Mallapragada S.K., Narasimhan B. Amphiphilic polyanhydrides for protein stabilization and release. Biomaterials 2007, 28:108-116.
12. Torres M.P., Wilson-Welder J., Lopac S.K., Phanse Y., Carrillo-Conde B., Ramer-Tait A., et al. Polyanhydride microparticles enhance dendritic cell antigen presentation and activation. Acta Biomater 2011, 7:2857-2864.
13. Kipper M.J., Wilson J.H., Wannemuehler M.J., Narasimhan B. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. J Biomed Mater Res A 2006, 76A:798-810.
14. Katti D.S., Lakshmi S., Langer R., Laurencin C.T. Toxicity, biodegradation and elimination of polyanhydrides. Adv Drug Deliv Rev 2002, 54:933-961.
15. Kumar N., Langer R.S., Domb A.J. Polyanhydrides: an overview. Adv Drug Deliv Rev 2002, 54:889-910.
16. Ulery B.D., Kumar D., Ramer-Tait A., Metzger D.W., Wannemuehler M.J., Narasimhan B. Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases. PLoS One 2011, 6:e17642.
17. Adler A.F., Petersen L.K., Wilson J.H., Torres M.P., Thorstenson J.B., Gardner S.W., et al. High throughput cell-based screening of biodegradable polyanhydride libraries. Comb Chem High Throughput Screen 2009, 12:634-645.
18. Petersen L.K., Xue L., Wannemuehler M.J., Rajan K., Narasimhan B. The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells. Biomaterials 2009, 30:5131-5142.
19. Torres M.P., Vogel B.M., Narasimhan B., Mallapragada S.K. Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms. J Biomed Mater Res A 2006, 76:102-110.
20. Vogel B.M., Mallapragada S.K. Synthesis of novel biodegradable polyanhydrides containing aromatic and glycol functionality for tailoring of hydrophilicity in controlled drug delivery devices. Biomaterials 2005, 26:721-728.
21. Determan A.S., Trewyn B.G., Lin V.S., Nilsen-Hamilton M., Narasimhan B. Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. J Control Release 2004, 100:97-109.
22. Determan A.S., Wilson J.H., Kipper M.J., Wannemuehler M.J., Narasimhan B. Protein stability in the presence of polymer degradation products: consequences for controlled release formulations. Biomaterials 2006, 27:3312-3320.
23. Ulery B.D., Phanse Y., Sinha A., Wannemuehler M.J., Narasimhan B., Bellaire B.H. Polymer chemistry influences monocytic uptake of polyanhydride nanospheres. Pharm Res 2009, 26:683-690.
24. Simon C.G., Eidelman N., Kennedy S.B., Sehgal A., Khatri C.A., Washburn N.R. Combinatorial screening of cell proliferation on poly(l-lactic acid)/poly(d,l-lactic acid) blends. Biomaterials 2005, 26:6906-6915.
25. Johnson R.A., Wichern D.W. Applied multivariate statistical analysis 2002, Prentice Hall. 5th ed.
26. Rosipal R., Kramer N. Subspace: latent structure and feature selection techniques 2006, Springer, Berlin/Heidelberg.
27. Rathinam V.A., Hoag K.A., Mansfield L.S. Dendritic cells from C57BL/6 mice undergo activation and induce Th1-effector cell responses against Campylobacter jejuni. Microbes Infect 2008, 10:1316-1324.
28. Uronen-Hansson H., Steeghs L., Allen J., Dixon G.L., Osman M., van der Ley P., et al. Human dendritic cell activation by Neisseria meningitidis: phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production. Cell Microbiol 2004, 6:625-637.
29. Yrlid U., Wick M.J. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter. J Immunol 2002, 169:108-116.
30. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
31. Bicerano J. Predictions of polymer properties 1996, Marcel Dekker, New York.
32. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004, 4:469-478.
33. Oh Y.K., Swanson J.A. Different fates of phagocytosed particles after delivery into macrophage lysosomes. J Cell Biol 1996, 132:585-593.
34. Endotoxin in health and disease 1999, Marcel Dekker, New York, NY. H. Brade, S.M. Opal, S.N. Vogel, D.C. Morrison (Eds.).
35. Yoshida M., Babensee J.E. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A 2004, 71A:45-54.
36. Yoshida M., Mata J., Babensee J.E. Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells. J Biomed Mater Res A 2007, 80A:7-12.
37. Caux C., Massacrier C., Vanbervliet B., Dubois B., Vankooten C., Durand I., et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994, 180:1263-1272.
38. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol 2002, 23:445-449.
39. Bartelt M., Shashkov A.S., Kochanowski H., Jann B., Jann K. Structure of the O-specific polysaccharide of the O22-antigen (LPS) from Escherichia coli O22:K13. Carbohydr Res 1994, 254:203-212.
40. Erridge C., Bennett-Guerrero E., Poxton I.R. Structure and function of lipopolysaccharides. Microbes Infect 2002, 4:837-851.
41. Rietschel E.T., Seydel U., Zahringer U., Schade U.F., Brade L., Loppnow H., et al. Bacterial endotoxin: molecular relationships between structure and activity. Infect Dis Clin North Am 1991, 5:753-779.
42. Ramos-Sanchez M.C., Rodriguez-Torres A., Leal J.A., Martin-Gil F.J., Martin-Gil J. Thermolytical techniques to characterize fungal polysaccharides and bacterial lipopolysaccharides. Biotechnol Prog 1991, 7:526-533.
43. Rodriguez-Torres A., Ramos-Sanchez M.C., Orduna-Domingo A., Martin-Gil F.J., Martin-Gil J. Differential scanning calorimetry investigations on LPS and free lipids A of the bacterial cell wall. Res Microbiol 1993, 144:729-740.
44. Rietschel E.T., Brade H., Brade L., Brandenburg K., Schade U., Seydel U., et al. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog Clin Biol Res 1987, 231:25-53.
45. Brocchini S., James K., Tangpasuthadol V., Kohn J. A combinatorial approach for polymer design. J Am Chem Soc 1997, 119:4553-4554.
46. Reddy S.T., van der Vlies A.J., Simeoni E., Angeli V., Randolph G.J., O'Neil C.P., et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 2007, 25:1159-1164.